We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Recent USPTO Activity May Signal Shift in Treatment of Pharmaceutical Patents in AIA Proceedings

23 September 2015

Pharmaceutical Online

The America Invents Act provides for adversarial proceedings for challenging patents in the United States Patent and Trademark Office — including inter partes review and post grant review — which are faster, cheaper, and have a lower burden of proof than litigation in federal court.

Read More: Recent USPTO Activity May Signal Shift in Treatment of Pharmaceutical Patents in AIA Proceedings

The team

Loading data